As of 2025-09-16, the Relative Valuation of Novocure Ltd (NVCR) is (74.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.68 USD, the upside of Novocure Ltd based on Relative Valuation is -687.3%.
The range of the Relative Valuation is (64.07) - (82.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.2x - 60.9x | 48.1x |
| Forward P/E multiples | 41.9x - 54.0x | 49.3x |
| Fair Price | (64.07) - (82.60) | (74.47) |
| Upside | -605.3% - -751.4% | -687.3% |
| Date | P/E |
| 2025-09-12 | -8.28 |
| 2025-09-11 | -8.33 |
| 2025-09-10 | -7.99 |
| 2025-09-09 | -8.28 |
| 2025-09-08 | -8.24 |
| 2025-09-05 | -8.03 |
| 2025-09-04 | -7.83 |
| 2025-09-03 | -7.90 |
| 2025-09-02 | -7.97 |
| 2025-08-29 | -8.06 |
| 2025-08-28 | -7.86 |
| 2025-08-27 | -7.79 |
| 2025-08-26 | -7.74 |
| 2025-08-25 | -7.65 |
| 2025-08-22 | -8.13 |
| 2025-08-21 | -7.79 |
| 2025-08-20 | -7.70 |
| 2025-08-19 | -7.89 |
| 2025-08-18 | -7.91 |
| 2025-08-15 | -7.67 |
| 2025-08-14 | -7.58 |
| 2025-08-13 | -7.60 |
| 2025-08-12 | -7.42 |
| 2025-08-11 | -7.13 |
| 2025-08-08 | -7.28 |
| 2025-08-07 | -7.53 |
| 2025-08-06 | -7.45 |
| 2025-08-05 | -7.48 |
| 2025-08-04 | -7.69 |
| 2025-08-01 | -7.40 |
| 2025-07-31 | -7.57 |
| 2025-07-30 | -7.17 |
| 2025-07-29 | -7.44 |
| 2025-07-28 | -7.61 |
| 2025-07-25 | -7.87 |
| 2025-07-24 | -8.20 |
| 2025-07-23 | -10.80 |
| 2025-07-22 | -10.66 |
| 2025-07-21 | -10.53 |
| 2025-07-18 | -10.48 |
| 2025-07-17 | -10.60 |
| 2025-07-16 | -10.85 |
| 2025-07-15 | -10.98 |
| 2025-07-14 | -11.39 |
| 2025-07-11 | -11.51 |
| 2025-07-10 | -12.07 |
| 2025-07-09 | -11.90 |
| 2025-07-08 | -11.45 |
| 2025-07-07 | -11.05 |
| 2025-07-03 | -11.58 |